Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO in Pregnancy With Immune Thrombocytopenia
NCT03492515Phase 3Unknown
- Sponsor
- Shandong University
- Start
- May 2018
- Primary completion
- May 2020
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of recombinant human thrombopoietin in immune thrombocytopenia (ITP) (3 arms), sponsored by Shandong University. Primary endpoint: Platelet count during delivery up to 2 years. Status: unknown.
02
Drugs
recombinant human thrombopoietin
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT03492515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03492515.